Cargando…
Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant
BACKGROUND: Tyrosinemia type 1 (HT1, MIM#276700) is caused by a deficiency in fumarylacetoacetate hydrolase (FAH) and it is associated with severe liver and renal disfunction. At present, the mutational FAH (15q25.1, MIM*613871) spectrum underlying HT1 in the Mexican population is unknown. The objec...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900384/ https://www.ncbi.nlm.nih.gov/pubmed/31568711 http://dx.doi.org/10.1002/mgg3.937 |
_version_ | 1783477346777432064 |
---|---|
author | Ibarra‐González, Isabel Fernández‐Lainez, Cynthia Alcántara‐Ortigoza, Miguel Angel González‐Del Angel, Ariadna Fernández‐Henández, Liliana Guillén‐López, Sara Belmont‐Martínez, Leticia López‐Mejía, Lizbeth Varela‐Fascinetto, Gustavo Vela‐Amieva, Marcela |
author_facet | Ibarra‐González, Isabel Fernández‐Lainez, Cynthia Alcántara‐Ortigoza, Miguel Angel González‐Del Angel, Ariadna Fernández‐Henández, Liliana Guillén‐López, Sara Belmont‐Martínez, Leticia López‐Mejía, Lizbeth Varela‐Fascinetto, Gustavo Vela‐Amieva, Marcela |
author_sort | Ibarra‐González, Isabel |
collection | PubMed |
description | BACKGROUND: Tyrosinemia type 1 (HT1, MIM#276700) is caused by a deficiency in fumarylacetoacetate hydrolase (FAH) and it is associated with severe liver and renal disfunction. At present, the mutational FAH (15q25.1, MIM*613871) spectrum underlying HT1 in the Mexican population is unknown. The objective of this study was to determine the FAH genotypes in eight nonrelated Mexican patients with HT1, who were diagnosed clinically. METHODS: Sequencing of FAH and their exon–intron boundaries and in silico protein modeling based on the crystallographic structure of mouse FAH. RESULTS: We identified pathogenic variants in 15/16 studied alleles (93.8%). Nine different variants were found. The most commonly detected HT1‐causing allele was NM_000137.2(FAH):c.3G > A or p.(?) [rs766882348] (25%, n = 4/16). We also identified a novel missense variant NM_000137.2(FAH):c.36C > A or p.(Phe12Leu) in a homozygous patient with an early and fatal acute form. The latter was classified as a likely pathogenic variant and in silico protein modeling showed that Phe‐12 residue substitution for Leu, produces a repulsion in all possible Leu rotamers, which in turn would lead to a destabilization of the protein structure and possible loss‐of‐function. CONCLUSION: HT1 patients had a heterogeneous mutational and clinical spectrum and no genotype–phenotype correlation could be established. |
format | Online Article Text |
id | pubmed-6900384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69003842019-12-20 Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant Ibarra‐González, Isabel Fernández‐Lainez, Cynthia Alcántara‐Ortigoza, Miguel Angel González‐Del Angel, Ariadna Fernández‐Henández, Liliana Guillén‐López, Sara Belmont‐Martínez, Leticia López‐Mejía, Lizbeth Varela‐Fascinetto, Gustavo Vela‐Amieva, Marcela Mol Genet Genomic Med Original Articles BACKGROUND: Tyrosinemia type 1 (HT1, MIM#276700) is caused by a deficiency in fumarylacetoacetate hydrolase (FAH) and it is associated with severe liver and renal disfunction. At present, the mutational FAH (15q25.1, MIM*613871) spectrum underlying HT1 in the Mexican population is unknown. The objective of this study was to determine the FAH genotypes in eight nonrelated Mexican patients with HT1, who were diagnosed clinically. METHODS: Sequencing of FAH and their exon–intron boundaries and in silico protein modeling based on the crystallographic structure of mouse FAH. RESULTS: We identified pathogenic variants in 15/16 studied alleles (93.8%). Nine different variants were found. The most commonly detected HT1‐causing allele was NM_000137.2(FAH):c.3G > A or p.(?) [rs766882348] (25%, n = 4/16). We also identified a novel missense variant NM_000137.2(FAH):c.36C > A or p.(Phe12Leu) in a homozygous patient with an early and fatal acute form. The latter was classified as a likely pathogenic variant and in silico protein modeling showed that Phe‐12 residue substitution for Leu, produces a repulsion in all possible Leu rotamers, which in turn would lead to a destabilization of the protein structure and possible loss‐of‐function. CONCLUSION: HT1 patients had a heterogeneous mutational and clinical spectrum and no genotype–phenotype correlation could be established. John Wiley and Sons Inc. 2019-09-30 /pmc/articles/PMC6900384/ /pubmed/31568711 http://dx.doi.org/10.1002/mgg3.937 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Ibarra‐González, Isabel Fernández‐Lainez, Cynthia Alcántara‐Ortigoza, Miguel Angel González‐Del Angel, Ariadna Fernández‐Henández, Liliana Guillén‐López, Sara Belmont‐Martínez, Leticia López‐Mejía, Lizbeth Varela‐Fascinetto, Gustavo Vela‐Amieva, Marcela Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant |
title | Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant |
title_full | Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant |
title_fullStr | Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant |
title_full_unstemmed | Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant |
title_short | Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant |
title_sort | mutational spectrum of mexican patients with tyrosinemia type 1: in silico modeling and predicted pathogenic effect of a novel missense fah variant |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900384/ https://www.ncbi.nlm.nih.gov/pubmed/31568711 http://dx.doi.org/10.1002/mgg3.937 |
work_keys_str_mv | AT ibarragonzalezisabel mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT fernandezlainezcynthia mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT alcantaraortigozamiguelangel mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT gonzalezdelangelariadna mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT fernandezhenandezliliana mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT guillenlopezsara mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT belmontmartinezleticia mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT lopezmejializbeth mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT varelafascinettogustavo mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant AT velaamievamarcela mutationalspectrumofmexicanpatientswithtyrosinemiatype1insilicomodelingandpredictedpathogeniceffectofanovelmissensefahvariant |